Ursula R. K.
- Country
- Germany
- Department
- N/A
Research Overview
- Obicetrapib vs Bempedoic Acid on Maximally Tolerated Lipid‑Lowering Therapy in High‑Risk Dyslipidemia: A Randomized Double‑Blind Study
- Effect of bempedoic acid/ezetimibe plus high‑intensity statin therapy on plaque regression in coronary atherosclerosis patients without prior CV events
- A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Hypercholesterolemia
Data & Insights
Has run more than one trial at 704 of 1453 partner sites.
Specializations
Cardiovascular Disease Management
This investigator specializes in treating patients with atherosclerotic cardiovascular disease (ASCVD) and hypercholesterolemia, focusing on innovative therapeutic approaches for cardiovascular risk reduction.
- Lipid Management
- Cardiovascular Risk Prevention
- Atherosclerosis Treatment
The research encompasses evaluation of novel therapeutic agents for managing cholesterol levels and reducing major adverse cardiovascular events.
Vascular Medicine
The investigator demonstrates expertise in treating deep vein thrombosis and related vascular conditions, with particular attention to thrombolytic therapy approaches.
- Thrombolysis
- Proximal DVT Management
- Vascular Disease Treatment
Clinical interests include evaluating novel therapeutic agents for clot dissolution and vascular health improvement.
Preventive Cardiology
The investigator focuses on coronary heart disease prevention and management of cardiovascular complications including myocardial infarction and ischemic stroke.
- Cardiovascular Risk Assessment
- Preventive Therapeutics
- Long-term Disease Management
Areas of interest include assessment of therapeutic interventions for reducing major cardiovascular events in high-risk patients.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.